Nucleotide analogs as novel anti-hepatitis B virus agents. 2005

Radhakrishnan P Iyer, and Seetharamaiyer Padmanabhan, and Guangrong Zhang, and John D Morrey, and Brent E Korba
Spring Bank Technologies Inc, Milford, MA 01757, USA. kiyer@springbanktech.com

During the past decade, nucleotide analogs have emerged as novel antiviral agents against hepatitis B virus. Adefovir dipivoxil, a prototype phosphonate analog, has been approved for chronic hepatitis B virus therapy, and additional phosphonate analogs and di- and tri-nucleotides are under development. Several innovative prodrug derivatizations have also been reported to improve the oral bioavailability of nucleotide analogs, which usually carry a negative charge.

UI MeSH Term Description Entries
D009711 Nucleotides The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleotide
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

Radhakrishnan P Iyer, and Seetharamaiyer Padmanabhan, and Guangrong Zhang, and John D Morrey, and Brent E Korba
April 2013, European journal of medicinal chemistry,
Radhakrishnan P Iyer, and Seetharamaiyer Padmanabhan, and Guangrong Zhang, and John D Morrey, and Brent E Korba
June 2004, Antimicrobial agents and chemotherapy,
Radhakrishnan P Iyer, and Seetharamaiyer Padmanabhan, and Guangrong Zhang, and John D Morrey, and Brent E Korba
December 2015, Antiviral chemistry & chemotherapy,
Radhakrishnan P Iyer, and Seetharamaiyer Padmanabhan, and Guangrong Zhang, and John D Morrey, and Brent E Korba
January 2015, Nucleosides, nucleotides & nucleic acids,
Radhakrishnan P Iyer, and Seetharamaiyer Padmanabhan, and Guangrong Zhang, and John D Morrey, and Brent E Korba
October 2016, European journal of medicinal chemistry,
Radhakrishnan P Iyer, and Seetharamaiyer Padmanabhan, and Guangrong Zhang, and John D Morrey, and Brent E Korba
May 1984, [Hokkaido igaku zasshi] The Hokkaido journal of medical science,
Radhakrishnan P Iyer, and Seetharamaiyer Padmanabhan, and Guangrong Zhang, and John D Morrey, and Brent E Korba
March 1972, Biochemical and biophysical research communications,
Radhakrishnan P Iyer, and Seetharamaiyer Padmanabhan, and Guangrong Zhang, and John D Morrey, and Brent E Korba
May 2012, Bioorganic & medicinal chemistry,
Radhakrishnan P Iyer, and Seetharamaiyer Padmanabhan, and Guangrong Zhang, and John D Morrey, and Brent E Korba
January 2017, MedChemComm,
Radhakrishnan P Iyer, and Seetharamaiyer Padmanabhan, and Guangrong Zhang, and John D Morrey, and Brent E Korba
August 2012, European journal of medicinal chemistry,
Copied contents to your clipboard!